172
Views
1
CrossRef citations to date
0
Altmetric
Original Articles

Relationship between second-trimester amniotic fluid and plasma levels of angiopoietin-2 and thrombomodulin with adverse pregnancy outcome

ORCID Icon, , , , &

References

  • [ACOG] American College of Obstetricians and Gynecologists' Committee on Practice Bulletins—Obstetrics. 2020. Gestational hypertension and preeclampsia: ACOG Practice Bulletin, Number 222. Obstetrics & Gynecology 135:e237–e260.
  • Charnock-Jones DS, Kaufmann P, Mayhew TM. 2004. Aspects of human fetoplacental vasculogenesis and angiogenesis. I. Molecular regulation. Placenta 25:103–113.
  • Daly C, Qian X, Castanaro C, Pasnikowski E, Jiang X, Thomson BR, et al. 2018. Angiopoietins bind thrombomodulin and inhibit its function as a thrombin cofactor. Scientific Reports 8:505.
  • De Moerloose P, Mermillod N, Amiral J, Reber G. 1998. Thrombomodulin levels during normal pregnancy, at delivery and in the postpartum: comparison with tissue-type plasminogen activator and plasminogen activator inhibitor-1. Thrombosis and Haemostasis 79:554–556.
  • D’Ippolito S, Di Nicuolo F, Papi M, Castellani R, Palmieri V, Masciullo V, et al. 2020. Expression of pinopodes in the endometrium from recurrent pregnancy loss women. Role of thrombomodulin and ezrin. Journal of Clinical Medicine 9:2634.
  • Fang Y, Li C, Shao R, Yu H, Zhang Q. 2018. The role of biomarkers of endothelial activation in predicting morbidity and mortality in patients with severe sepsis and septic shock in intensive care: a prospective observational study. Thrombosis Research 171:149–154.
  • Geva E, Ginzinger DG, Zaloudek CJ, Moore DH, Byrne A, Jaffe RB. 2002. Human placental vascular development: vasculogenic and angiogenic (branching and nonbranching) transformation is regulated by vascular endothelial growth factor-A, angiopoietin-1, and angiopoietin-2. The Journal of Clinical Endocrinology and Metabolism 87:4213–4224.
  • Hirokoshi K, Maeshima Y, Kobayashi K, Matsuura E, Sugiyama H, Yamasaki Y, et al. 2005. Increase of serum angiopoietin-2 during pregnancy is suppressed in women with preeclampsia. American Journal of Hypertension 18:1181–1188.
  • Isermann B, Hendrickson SB, Hutley K, Wing M, Weiler H. 2001. Tissue-restricted expression of thrombomodulin in the placenta rescues thrombomodulin-deficient mice from early lethality and reveals a secondary developmental block. Development 128:827–838.
  • Isermann B, Sood R, Pawlinski R, Zogg M, Kalloway S, Degen JL, et al. 2003. The thrombomodulin-protein C system is essential for the maintenance of pregnancy. Nature Medicine 9:331–337.
  • Kappou D, Sifakis S, Androutsopoulos V, Konstantinidou A, Spandidos DA, Papantoniou N, et al. 2014. Placental mRNA expression of angiopoietins (Ang)-1, Ang-2 and their receptor Tie-2 is altered in pregnancies complicated by preeclampsia. Placenta 35:718–723.
  • Leinonen E, Wathén KA, Alfthan H, Ylikorkala O, Andersson S, Stenman UH, et al. 2010. Maternal serum angiopoietin-1 and -2 and tie-2 in early pregnancy ending in preeclampsia or intrauterine growth retardation. The Journal of Clinical Endocrinology and Metabolism 95:126–133.
  • Maruyama I, Bell CE, Majerus PW. 1985. Thrombomodulin is found on endothelium of arteries, veins, capillaries, and lymphatics, and on syncytiotrophoblast of human placenta. The Journal of Cell Biology 101:363–371.
  • Minakami H, Takahashi T, Izumi A, Tamada T. 1993. Increased levels of plasma thrombomodulin in preeclampsia. Gynecologic and Obstetric Investigation 36:208–210.
  • Okamoto T, Tanigami H, Suzuki K, Shimaoka M. 2012. Thrombomodulin: a bifunctional modulator of inflammation and coagulation in sepsis. Critical Care Research and Practice 2012:614545.
  • Salomon LJ, Alfirevic Z, Da Silva Costa F, Deter RL, Figueras F, Ghi T, et al. 2019. ISUOG Practice Guidelines: ultrasound assessment of fetal biometry and growth. Ultrasound in Obstetrics & Gynecology 53:715–723.
  • Sood R, Sholl L, Isermann B, Zogg M, Coughlin SR, Weiler H. 2008. Maternal Par4 and platelets contribute to defective placenta formation in mouse embryos lacking thrombomodulin. Blood 112:585–591.
  • Varol FG, Ozgen L, Sayin NC, Demir M. 2009. Correlation between maternal plasma thrombomodulin and infant birth weight in hypertensive disorders of pregnancy. Clinical and Applied Thrombosis/Hemostasis 15:166–170.
  • Wang Y, Tasevski V, Wallace EM, Gallery ED, Morris JM. 2007. Reduced maternal serum concentrations of angiopoietin-2 in the first trimester precede intrauterine growth restriction associated with placental insufficiency. British Journal of Gynecology 114:1427–1431.
  • Wienhard J, Bielska B, Münstedt K, Lang U, Zygmunt M. 2002. Increased endothelial thrombomodulin (TM) expression in pregnancies complicated by IUGR. Journal of Perinatal Medicine 30:322–328.
  • Wiwanitkit V. 2008. Correlation between thrombomodulin and severe preeclampsia: a summary. Clinical and Applied Thrombosis/Hemostasis 14:99–101.
  • Woolnough C, Wang Y, Kan CY, Morris JM, Tasevski V, Ashton AW. 2012. Source of angiopoietin-2 in the sera of women during pregnancy. Microvascular Research 84:367–374.
  • Zhang EG, Smith SK, Baker PN, Charnock-Jones DS. 2001. The regulation and localization of angiopoietin-1, -2, and their receptor Tie2 in normal and pathologic human placentae. Molecular Medicine 7:624–635.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.